VRG Therapeutics is thrilled to announce that our project, "Development of a high-efficiency drug discovery platform combining advanced laboratory techniques, computational structure modeling, and Big Data analysis," with a total budget of EUR 1 million has been selected as a winner of the "Fast Track" grant by NRDIO - National Research Development and Innovation Office (NKFIH).

AI is revolutionizing preclinical drug development, from identifying new targets to designing novel drugs. This opportunity will allow us to enhance our miniprotein drug discovery platform (AI-MPRO) and stay ahead of the curve.

We are excited to take this next step in transforming the drug discovery landscape and are grateful for the support that will help us drive innovation and the future of healthcare.